2022
DOI: 10.2217/fmb-2022-0031
|View full text |Cite
|
Sign up to set email alerts
|

Long-Term Outcomes of Pediatric Infections: From Traditional Infectious Diseases to Long Covid

Abstract: There is limited evidence available on the long-term impact of SARS-CoV-2 infection in children. In this article, the authors analyze the recent evidence on pediatric long covid and lessons learnt from a pediatric post-covid unit in Rome, Italy. To gain a better understanding of the concerns raised by parents and physicians in relation to the potential long-term consequences of this novel infection, it is important to recognize that long-term effect of a post-infectious disease is not a new phenomenon.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

6
98
1
3

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

4
5

Authors

Journals

citations
Cited by 75 publications
(108 citation statements)
references
References 134 publications
6
98
1
3
Order By: Relevance
“…The long-term effects of SARS-CoV-2 infection in children are little understood [ 91 ]. To date, the majority of investigations have focused on adult populations.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The long-term effects of SARS-CoV-2 infection in children are little understood [ 91 ]. To date, the majority of investigations have focused on adult populations.…”
Section: Discussionmentioning
confidence: 99%
“…However, a subset of children appear to recover from their initial COVID-19 infection but have signs and symptoms and may be diagnosed with long-COVID [ 92 ]. Severe acute infection might be related with chronic symptoms; however, symptoms might be also related with chronic inflammation, autoimmunity, chronic endotheliopathy, microthrombosis, or viral persistence [ 91 ]. Microbiota composition changes might also play a role in long-COVID.…”
Section: Discussionmentioning
confidence: 99%
“…For this reason, it seems implicit that the task of pediatricians, as well as of the general practitioner, is essentially to prevent, but also to evaluate the possibility of attenuating the symptoms with the use of the biologically plausible elements summarized in Table 1 [138]. A multi-disciplinary management is necessary, and the possible use of different nutraceuticals and essential elements, already suggested for COVID-19 patients [21][22][23][24] and in children with different inflammatory disease, seems reasonable [135,139,140].…”
Section: Future Perspectivesmentioning
confidence: 99%
“…Divergent PASC phenotypes also complicate investigation of PASC epidemiology and pathophysiology ( 11 , 12 , 14 ). Recent surveys of large population groups post–acute COVID-19 that include pre-pandemic comparator groups and involvement of more than one organ system suggest a PASC incidence of approximately 14% in adults ( 15 ) and approximately 21% in children and adolescents ( 16 ). In contrast, studies reporting much higher incidence rates often lack objective findings documented by quantitative assays ( 16 , 17 ).…”
Section: Introductionmentioning
confidence: 99%